- Enhanced induction of Bax gene expression in H460 and H1299 cells with the combined treatment of cisplatin and adenovirus mediated wt-p53 gene transfer
-
Choi JH, Ahn KS, Kim JG, Hong YS
- KMID: 927130
- Exp Mol Med.
- 2000 Mar;32(1):23-28.
Cytotoxic effect of either cisplatin or p53 gene transfection of lung cancer cells may be different depending on the p53 status of cells. We investigated cytotoxic effects on the combined... -
- CITED
-
- Close
- SHARE
-
- Close
- miR-9 and let-7g enhance the sensitivity to ionizing radiation by suppression of NFkappaB1
-
Arora H, Qureshi R, Jin S, Park AK, Park WY
- KMID: 1009969
- Exp Mol Med.
- 2011 May;43(5):298-304.
- doi: 10.3858/emm.2011.43.5.031
The activation of nuclear factor-kappa B1 (NFkappaB1) in cancer cells may confer resistance to ionizing radiation (IR). To enhance the therapeutic efficiency of IR in lung cancer, we screened for... -
- CITED
-
- Close
- SHARE
-
- Close
- In vivo Recombinant Adenovirus-mediated p53 Gene Therapy in a Syngeneic Rat Model for Colorectal Cancer
-
Baek JH, Agarwal ML, Tubbs RR, Vladisavljevic A, Tomita H, Bukowski R, Milsom JW, Kim JM, Kwak JY
- KMID: 1778565
- J Korean Med Sci.
- 2004 Dec;19(6):834-841.
- doi: 10.3346/jkms.2004.19.6.834
The p53 gene has a significant role in controlling genomic stability of cancer. The purpose of this study was to evaluate the tumor response of allograft colorectal tumor treated with... -
- CITED
-
- Close
- SHARE
-
- Close
- Ischemic postconditioning protects cardiomyocytes against ischemia/reperfusion injury by inducing MIP2
-
Zhu HL, Wei X, Qu SL, Zhang C, Zuo XX, Feng YS, Luo Q, Chen GW, Liu MD, Jiang L, Xiao XZ, Wang KK
- KMID: 1022118
- Exp Mol Med.
- 2011 Aug;43(8):437-445.
- doi: 10.3858/emm.2011.43.8.049
Cardiomyocytes can resist ischemia/reperfusion (I/R) injury through ischemic postconditioning (IPoC) which is repetitive ischemia induced during the onset of reperfusion. Myocardial ischemic preconditioning up-regulated protein 2 (MIP2) is a member... -
- CITED
-
- Close
- SHARE
-
- Close
